Financials
- Market Capitalization 3.59 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
41.95
市销率
8.46
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1563 | DNLI Denali Therapeutics Inc. - Common Stock | 22.54 USD | -1.36% | -7.66% | -4.29% | +39.39% | 3.60 B USD | ||
| 1570 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 83.23 USD | +0.57% | +16.29% | +34.96% | +25.99% | 3.65 B USD | ||
| 1590 | ABCL AbCellera Biologics Inc. - Common Shares | 11.80 USD | +3.87% | -4.30% | +97.65% | +195.74% | 3.62 B USD | ||
| 1630 | GPCR Structure Therapeutics Inc - American Depositary Shares | 47.03 USD | -1.61% | -4.89% | -4.80% | +75.88% | 3.35 B USD |